治疗阿尔茨海默病的乙酰胆碱酯酶抑制剂的分子设计:从多位点抑制剂到一药多靶

被引：16

作者：

杨文超

孙琦

喻宁熙

朱晓磊

杨光富

机构：

[1] 农药与化学生物学教育部重点实验室华中师范大学化学学院

来源：

药学学报 | 2012年 / 03期

关键词：

阿尔茨海默病; 乙酰胆碱酯酶抑制剂; 多位点抑制剂; 一药多靶; 分子设计;

D O I：

10.16438/j.0513-4870.2012.03.007

中图分类号：

R749.16 [];

学科分类号：

100203 ;

摘要：

阿尔茨海默病(Alzheimer's disease,AD)是一种病因尚不明确且致病机制极为复杂的神经退行性疾病,严重威胁老年人的健康并对整个社会发展带来沉重的负担。设计开发治疗阿尔茨海默病的药物一直是药物研发领域的热点和难点,其中尤以乙酰胆碱酯酶(acetylcholinesterase,AChE)抑制剂的研究最为活跃并已在临床中成功应用。然而,现有商品化AChE抑制剂的临床治疗效果有限,并且都伴随不同程度的毒副作用。因此,寻找高效、低毒的多重结合位点的AChE抑制剂和针对多重作用靶标的多功能抑制剂(即一药多靶)成为AChE抑制剂分子设计的主要发展方向。本文结合近年来的研究进展,从代表性AChE抑制剂的化学结构和结合模式出发,对AChE抑制剂分子设计的发展历程及最新成果进行了综述。

引用

页码：313 / 321+258 +258

页数：10

共 11 条

[1]

Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors[J] . Anding Shi,Ling Huang,Chuanjun Lu,Feng He,Xingshu Li.Bioorganic & Medicinal Chemistry . 2011 (7)

[2]

Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease[J] . Abdelouahid Samadi,Mourad Chioua,Irene Bolea,Cristóbal de los Ríos,Isabel Iriepa,Ignacio Moraleda,Agatha Bastida,Gerard Esteban,Mercedes Unzeta,Enrique Gálvez,José Marco-Contelles.European Journal of Medicinal Chemistry . 2011 (9)

[3] Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease [J].

Tasso, B. ;

Catto, M. ;

Nicolotti, O. ;

Novelli, F. ;

Tonelli, M. ;

Giangreco, I. ;

Pisani, L. ;

Sparatore, A. ;

Boido, V. ;

Carotti, A. ;

Sparatore, F. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (06) :2170-2184

[4] Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase [J].

Huang, Ling ;

Luo, Zonghua ;

He, Feng ;

Lu, Jing ;

Li, Xingshu .

BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (12) :4475-4484

[5] Current and future management of Alzheimer's disease [J].

Gauthier, Serge ;

Poirier, Judes .

ALZHEIMERS & DEMENTIA, 2008, 4 (01) :S48-S50

[6]

Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE[J] . Bioorganic & Medicinal Chemistry . 2005 (24)

[7]

Cholinesterase inhibitors: new roles and therapeutic alternatives[J] . Ezio Giacobini.Pharmacological Research . 2004 (4)

[8]

Synthesis and evaluation of tacrine–E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease[J] . Dong Shao,Chunyan Zou,Cheng Luo,Xican Tang,Yuanchao Li.Bioorganic & Medicinal Chemistry Letters . 2004 (18)

[9]

Structure of acetylcholinesterase complexed with E2020 (Aricept ? ): implications for the design of new anti-Alzheimer drugs[J] . Gitay Kryger,Israel Silman,Joel L Sussman.Structure . 1999 (3)

[10]

Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors[J] . Paul R. Carlier,Da-Ming Du,Yifan Han,Jing Liu,Yuan-Ping Pang.Bioorganic & Medicinal Chemistry Letters . 1999 (16)

← 1 2 →